Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

NKG2D Attenuation Boosts NK Cell Persistence in Solid Tumors

Lowering NKG2D stimulation reshaped intratumoral NK cells, preserved stem-like function, and improved persistence after adoptive transfer in solid tumors.

By Dr. Revathy Mohan V.R., MBBS · Oct 31, 2026 · 6 min read

Oncology·BBC Dental

Neuroblastoma vaccine trial offers family hope for toddler Teddy Sloman

Teddy Sloman, 3, is heading to New York for a neuroblastoma vaccine trial after scans showed no active…

Oct 31, 2026

Oncology·Fierce HC

HHS launches breast cancer screening initiative amid policy push

HHS has launched a breast cancer screening initiative, signaling renewed federal attention to detection access and prevention gaps.

Oct 31, 2026

Oncology·Becker H

Hackensack Meridian First in Northeast to Offer Pixclara for Brain Cancer Imaging

Hackensack Meridian is the first hospital network in the Northeast to offer Pixclara, an FDA-approved PET imaging drug…

Oct 31, 2026

Oncology·BBC Dental

Kent lung cancer screening expands to smokers and ex-smokers

Free lung screening is expanding across Kent after the programme detected more than 120 cancers, mostly at stage…

Oct 31, 2026

Oncology·WHO

IARC launches IARC-MonDO database for carcinogen evaluations

IARC launches IARC-MonDO, a searchable database of carcinogen evaluations, evidence streams, and classifications for cancer prevention work.

Oct 31, 2026

Oncology·JCI

PHB linked to aggressive neuroblastoma and dedifferentiation

High PHB expression tracks with 17q gain, poor prognosis, and loss of neuronal differentiation in neuroblastoma, while PHB…

Oct 30, 2026

Oncology·Oral Health

Mouth Cancer Prevention Gap Worsens as Late Diagnosis Persists

Oral Health Foundation warns that poor awareness, uneven prevention and late diagnosis are leaving mouth cancer patients at…

Oct 30, 2026

Oncology·Nature

FLT3-ITD Microclones Found in 10.4% of Elderly AML Patients

Ultrasensitive NGS found FLT3-ITD microclones in elderly AML patients missed by fragment analysis, with survival impact mainly in…

Oct 30, 2026

Oncology·ScienceDaily

Rhabdomyosarcoma Study Finds Hidden Aggressive Childhood Cancer Cells

Single-cell and spatial profiling revealed aggressive cell states inside lower-risk rhabdomyosarcoma, offering a route to earlier risk detection.

Oct 30, 2026

Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.